The FDA approval of zongertinib (Hernexeos) has introduced a novel, precision-targeted treatment approach for patients with HER2-mutant non–small cell lung cancer (NSCLC), a biologically aggressive subtype often associated with high rates of…
Category: 6. Business
-
Stimuli-Responsive MXene Nanomaterials for Advanced Antitumor Drug Del
Introduction
Cancer, a complex malignant disease characterized by uncontrolled cell proliferation and metastasis, remains one of the most formidable challenges in global public health.1 According to the latest global cancer statistics, an…
Continue Reading
-
Hapoalim’s Bit app to pay 4% annual interest on deposits
The interest rate will be paid up to a maximum deposit of NIS 20,000.
Continue Reading
-
Systemic Therapy for Sjögren Closer With Phase 3 Success – Medscape
- Systemic Therapy for Sjögren Closer With Phase 3 Success Medscape
- Novartis drug reduces Sjögren’s activity, patient burden in late-stage trials despite notable placebo effect Fierce Biotech
- Novel Biologic for Sjogren’s Clears Penultimate…
Continue Reading
-
Construction of a Risk Score Model for Predicting Airway Management in
Introduction
Oral and maxillofacial space infections (OMSI) represent a considerable and growing clinical burden, accounting for more than 144,000 surgical procedures in Germany alone (2005–2022), with standardized incidence rates increasing…
Continue Reading
-
Do Inflammatory and Nutritional Markers Predict Prognosis in Metastati
Introduction
Lung cancer is the second most common type of cancer in women and men, but it is the most important cause of cancer-related deaths.1 Non-small-cell lung cancer (NSCLC) constitutes approximately 85% of all lung cancers.2 Currently,…
Continue Reading
-
Exploring the Median Effective Dose of Remimazolam for Anesthesia Indu
Introduction
In recent years, ERCP has emerged as an essential, minimally invasive interventional procedure for diagnosing and treating biliary and pancreatic disorders.1 Annually, over one million individuals worldwide undergo ERCP.2…
Continue Reading
-
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System
FRANKLIN LAKES, N.J., Nov. 3, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global…
Continue Reading
-
Neutrophils and neutrophil extracellular traps: double-edged swords in cancer pathophysiology and therapy resistance | Cell Communication and Signaling
Xu M, Xu H, Ling YW, Liu JJ, Song P, Fang ZQ, Yue ZS, Duan JL, He F, Wang L. Neutrophil extracellular traps-triggered hepatocellular senescence exacerbates lipotoxicity in non-alcoholic steatohepatitis. J Adv Res. 2025;S2090–1232(25):00175–4.
Continue Reading
-
Fastmarkets implements manganese ore base brand adjustment from Nov 1: pricing notice
Fastmarkets’ MB-MNO-0001 manganese ore high grade index tracks the spot prices of high-grade manganese ore in the CIF China market, with manganese content and other chemical specifications set to match the prevailing…
Continue Reading